Poland· PL-100407862

Zahron ASA

A rosuvastatin und acetylsalicylsäure product containing rosuvastatinum + acidum acetylsalicylicum, registered in Poland by Adamed Pharma S.A.. The same ATC class is registered in 2 of our 19 countries.

ATC C10BX05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedZahron ASAATCC10BX05REGISTER NO.PL-100407862PACKS LISTED7CHECKEDSeptember 27, 2026

Where it is registered

Rosuvastatin und acetylsalicylsäure is registered in 2 of 19 countries.

Countries holding a registration under ATC C10BX05 (rosuvastatin und acetylsalicylsäure), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Rosuvastatin und acetylsalicylsäure · ATC C10BX05

2 / 19 countries

  • Italyprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Rosuvastatinum + Acidum acetylsalicylicum
Manufacturer
Adamed Pharma S.A.
Country
Poland (PL)
ATC code
C10BX05
ATC class
Rosuvastatin und Acetylsalicylsäure
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    05909991441784
  • gtin
    05909991441791
  • gtin
    05909991441807
  • gtin
    05909991441814
  • gtin
    05909991441821
  • gtin
    05909991441838
  • gtin
    05900411013451

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rosuvastatin und acetylsalicylsäure in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rosuvastatin und acetylsalicylsäure products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Rosuass
  • Bulgaria · Розувастатин/Ацетилсалицилова Киселина Адамед, Росстааси
  • Cyprus · Rosu-Asa
  • Germany · Rosuass
  • Spain · Aspifox, Roasax
  • Greece · Rosu-Asa, Rosuvastatin + Acetylsalicylic Acid/ Rafarm
  • Croatia · Rosix Duo
  • Hungary · Xeterduo
  • Italy · Asadrox, Lugarexia
  • Portugal · Aspifox, Estasp
  • Slovenia · Belorostin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ecd09e17-0e15-447b-91ed-35f0c990d2c6
GET /v1/drugs/ecd09e17-0e15-447b-91ed-35f0c990d2c6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "5 mg + 100 mg",
  "packaging": "05909991441784 ¦ Rp ¦ 138269\n28 kaps.\n05909991441791 ¦ Rp ¦ 138270\n30 kaps.\n05909991441807 ¦ Rp ¦ 138271\n56 kaps.\n05909991441814 ¦ Rp ¦ 138272\n60 kaps.\n05909991441821 ¦ Rp ¦ 138273\n90 kaps.\n05909991441838 ¦ Rp ¦ 138274\n100 kaps.\n05900411013451 ¦ Rp ¦ 160698\n10 kaps.",
  "substance": "Rosuvastatinum calicum 5.2 mg + Acidum acetylsalicylicum 100 mg",
  "common_name": "Rosuvastatinum + Acidum acetylsalicylicum",
  "pl_product_id": "100407862",
  "pozwolenie_nr": "26115",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about rosuvastatin und acetylsalicylsäure.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.